For this reason, much research has been conducted into developing subunit vaccines using components of the virus, particularly the viral envelope glycoprotein (Env), which can elicit neutralizing antibodies capable of preventing HIV-1 infection [1,2]. This evidence concerns the gene ERVW-1 and HIV-1 infection.